I. Novikov

I. Novikov

Auto-generated profile, based on publicly available information

I. Novikov

«Almaty Regional Multidisciplinary Clinic» CSE on REM

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Actual Problems of Theoretical and Clinical Medicine
Verified
Journal Article
Closed access
INI. I. Novikov
I. I. Novikov
Relevance. Breast cancer is characterized by substantial heterogeneity in clinical course and outcomes, which is largely determined by the biological diversity of tumors. Molecular biological markers, including receptor status and the Ki-67 proliferation index, play a key role in disease prognosis; however, their significance may vary across populations. Objective: To evaluate the prognostic significance of receptor status (ER, PR, HER2) and the Ki-67 proliferation index in the risk stratification of mortality among patients with breast cancer based on the results of univariate analysis. Materials and Methods. A retrospective cohort analysis was performed, including 729 patients with primary breast cancer registered between 2018 and 2022 according to the Almaty Cancer Registry. The primary endpoint was mortality. Statistical analysis included the chi-square test, logistic regression, and ROC analysis. Results. ER and PR status demonstrated a statistically significant association with mortality risk (p < 0,001): negative receptor status was associated with a higher risk of death. Logistic regression revealed a protective effect of ER (Exp(B) = 0,883) and PR (Exp(B) = 0,424) expression. ROC analysis showed moderate discriminative ability for ER (AUC = 0,614) and PR (AUC = 0,622). HER2 status was not significantly associated with mortality (p = 0,531). The Ki-67 index was significantly associated with increased mortality risk (Exp(B) = 1,015 for each 1 % increase; p < 0,001), demonstrating moderate prognostic accuracy (AUC = 0,606). The integrated molecular-biological phenotype was also significantly associated with outcomes (p < 0,001): the luminal A subtype showed the most favorable prognosis, whereas the triple-negative phenotype was associated with the poorest outcomes. Conclusion. ER and PR receptor status, as well as the Ki-67 index, are significant prognostic factors for mortality risk in breast cancer. HER2 status did not demonstrate prognostic significance in this cohort

30 September 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
VMV. Makarov
V. Makarov
EBE. Baimuhametov
E. Baimuhametov
EМE. Мusanov
E. Мusanov
SOS. Olzhayev
S. Olzhayev
INI. Novikov
I. Novikov
RКR. Каdyrbayeva
R. Каdyrbayeva
Relevance: Several studies have shown that non-intubation surgical interventions, especially, have proven themselves well in patients with low reserve of the cardiovascular and respiratory systems, as well as in the diagnosis of interstitial lung diseases. The study aimed to describe the experience of introducing into clinical practice surgical interventions without intubation on spontaneous breathing for malignant neoplasms of the lungs and mediastinal organs. of Thoracic Surgeons // Ann. Transl. Med. – 2015. – Vol. 3(3). https:// doi.org/10.3978/J.ISSN.2305-5839.2015.01.34 10. Galetin T., Galetin T., Lopez-Pastorini A., Lopez-Pastorini A., Kosse N., Koryllos A., Koryllos A., Stoelben E., Stoelben E. Video-assisted Thoracoscopic Surgery in Local Anaesthesia and Analgosedation – A Survey of the Members of the German Society of Thoracic Surgeons // Zentralblatt Fur Chirurgie. – 2020. – Vol. 145(3). – P. 278-283. https://doi.org/10.1055/A-0988-0085 11. Wang M.L., Hung M.H., Hsu H.H., Chan K.C., Cheng Y.J., Chen J.S. Non-intubated thoracoscopic surgery for lung cancer in patients with impaired pulmonary function // Ann. Transl. Med. – 2019. – Vol. 7(3). – P. 40. https://doi.org/10.21037/ATM.2018.11.58 12. Gonzalez-Rivas D., Bonome C., Fieira E., Aymerich H., Fernandez R., Delgado M., Mendez L., De la Torre M. Non-intubated video-assisted thoracoscopic lung resections: The future of thoracic surgery? // Eur. J. Cardio-Thorac. Surg. – 2016. – Vol. 49(3). – P. 721- 731. https://doi.org/10.1093/EJCTS/EZV136 13. Pompeo E. State of the art and perspectives in non-intubated thoracic surgery // Ann. Transl. Med. – 2014. – Vol. 2(11). https://doi. org/10.3978/J.ISSN.2305-5839.2014.10.01 14. Wen Y., Liang H., Qiu G., Liu Z., Liu J., Ying W., Liang W., He J. Non-intubated spontaneous ventilation in video-assisted thoracoscopic surgery: a meta-analysis // Eur. J. Cardio-Thorac. Surg. – 2020. – Vol. 57. – P. 428-437. https://doi.org/10.1093/ejcts/ezz279 15. Zhang X.X., Song C.T., Gao Z., Zhou B., Wang H.B., Gong Q., Li B., Guo Q., Li H.F. A comparison of non-intubated video-assisted thoracic surgery with spontaneous ventilation and intubated videoassisted thoracic surgery: a meta-analysis based on 14 randomized controlled trials // J. Thorac. Surg. – 2021. – Vol. 13(3). – P. 1624. https://doi.org/10.21037/JTD-20-3039 16. Elkhayat H., Gonzalez-Rivas D. Non-intubated uniportal videoassisted thoracoscopic surgery // J. Thorac. Surg. – 2019. – Vol. 11. – P. S220–S222. https://doi.org/10.21037/JTD.2019.02.05 17. Yu M.G., Jing R., Mo Y.J., Lin F., Du X.K., Ge W.Y., Dai H.J., Hu Z.K., Zhang S.S., Pan L.H. Non-intubated anesthesia in patients undergoing video-assisted thoracoscopic surgery: A systematic review and metaanalysis // PLOS ONE. – 2019. – Vol. 14(11). – P. e0224737. https://doi. org/10.1371/JOURNAL.PONE.0224737 18. Zardo P., Zinne N., Logemann F., Gras C., Rivas D.G. Nonintubated uniportal video-assisted thoracoscopic surgery-lobectomy in Germany-the first 2 cases // J. Visual. Surg. – 2018. – Vol. 4. – P. 178-178. https://doi.org/10.21037/jovs.2018.07.18 19. Canet J., Gallart L., Gomar C., Paluzie G., Valle J., Castillo J., Sabaté S., Mazo V., Briones Z., Math M., Sanchis J. Prediction of Postoperative Pulmonary Complications in a Population-based Surgical Cohort // Anesthesiology. – 2010. – Vol. 113. – P. 1338-1350. http://links.lww.com/ ALN/A646 20. Anile M., Vannucci J., Ferrante F., Bruno K., De Paolo D., Bassi M., Pugliese F., Venuta F. Non-Intubated Thoracic Surgery: Standpoints and Perspectives // Front. Surg. – 2022. – P. 9. https://doi.org/10.3389/ FSURG.2022.937633 21. Furák J., Paróczai D., Burián K., Szabó Z., Zombori T. Oncological advantage of non-intubated thoracic surgery: Better compliance of adjuvant treatment after lung lobectomy // Thorac. Cancer. – 2020. – Vol. 11(11). – P. 3309-3316. https://doi.org/10.1111/1759-7714.13672 22. AlGhamdi Z.M., Lynhiavu L., Moon Y.K., Moon M.H., Ahn S., Kim Y., Sung S.W. Comparison of non-intubated versus intubated video-assisted thoracoscopic lobectomy for lung cancer // J. Thorac. Surg. – 2018. – Vol. 10(7). – P. 4236-4243. https://doi.org/10.21037/ JTD.2018.06.163 АҢДАТПА ҚАЗАҚСТАН РЕСПУБЛИКАСЫНДА ӨКПЕ ОБЫРЫ КЕЗІНДЕ ИНТУБАЦИЯЛЫҚ БЕЙНЕ-АССИСТЕНТТЕЛГЕН ТОРАКОСКОПИЯЛЫҚ РЕЗЕКЦИЯЛАРСЫЗ ҚОЛДАНУДЫҢ АЛҒАШҚЫ ТӘЖІРИБЕСІ В.А. Макаров1 , Э.Т. Баймухаметов1 , Е.Т. Мусанов1 , С.Т. Олжаев1 , И.И. Новиков1 , Б.Ж. Бекботаев1 , Б.Ж. Аджибаев1 , Б.А. Маханбетов1 , С.С. Оспанов1 , А.С. Ожарова1 , Р.Е. Кадырбаева2 1 «Алматы Жергілікті Көпсалалы Клиникасы» ШЖҚКШ, Алматы, Қазақстан Республикасы; 2 «Қазақ онкология және радиология ғылыми-зерттеу институты» АҚ, Алматы, Қазақстан Республикасы Өзектілігі: Бірқатар зерттеулер көрсеткендей, интубациясыз хирургиялық араласулар, әсіресе жүрек-қан тамырлары мен тыныс алу жүйесінің резерві төмен науқастарда, сондай-ақ өкпенің интерстициальды ауруларын диагностикалауда жақсы нәтиже көрсетті. Зерттеудің мақсаты: Өкпе мен медиастинальды органдардың қатерлі ісіктері кезінде өздігінен тыныс алуда интубациясыз хирургиялық араласуды клиникалық тәжірибеге енгізу. Әдістері:...

10 October 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
VMV. Makarov
V. Makarov
EBE. Baimuhametov
E. Baimuhametov
EМE. Мusanov
E. Мusanov
SOS. Olzhayev
S. Olzhayev
INI. Novikov
I. Novikov
RКR. Каdyrbayeva
R. Каdyrbayeva
Relevance:Several studies have shown that non-intubation surgical interventions, especially, have proven themselves well in patients with low reserve of the cardiovascular and respiratory systems, as well as in the diagnosis of interstitial lung diseases. The study aimed to describe the experience of introducing into clinical practice surgical interventions without intubation on spontaneous breathing for malignant neoplasms of the lungs and mediastinal organs. Methods: two clinical cases are described of the main points of the anesthesia and technical features of surgical intervention. Results: A surgery in two patients with peripheral lung cancer was performed. In the first case, the operation included NI-VATS on the right and the resection of the upper (S2) and lower lobe (S6, S9); in the second case – NI-VATS on the right, lower lobectomy, and lymph node dissection. Based on the results of histological examination, both patients were diagnosed with NSCLC in the initial stages. Postoperative chemoradiotherapy is not indicated. The patients were registered at the dispensary in clinical group III. Conclusion: As the literature data and our preliminary results of NI-VATS show, surgical interventions in the surgical treatment of lung cancer have places to be and should be widely introduced into clinical practice in oncothoracic departments of the Republic of Kazakhstan.

30 September 2022 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
VMV. Makarov
V. Makarov
DKD. Kaidarova
D. Kaidarova
SYS. Yessentayeva
S. Yessentayeva
JKJ. Kalmatayeva
J. Kalmatayeva
Madina MansurovaMadina Mansurova
Madina Mansurova
INI. Novikov
I. Novikov
Relevance: The 5-year overall survival rate(s) in NSCLC p-stage IA is 73%, and the recurrence rate in radically treated patients is almost 10%. The study aimed to evaluate the prognostic significance of several clinical and morphological factors and apply machine learning algorithms to predict the results of the overall survival of patients with lung cancer. Methods: The forms 030-6/y C34 – lung cancer (n=19,379) from the EROB database for 2014-2018 were analyzed, and the impact of risk factors on overall survival was assessed using the Kaplan-Meier method. Accordingly, the training data set for constructing forecasting models included 19,379 observations and 15 factors. The machine learning algorithms such as Random Forest Classifier, Gradient Boosting Classifier, Logistic Regression Model, Decision Tree Classifier, and K Nearest Neighbors (KNN) Classifier were implemented in the Python programming language. The results were evaluated by constructing an error matrix and calculating classification metrics: the proportion of correctly classified objects (accuracy) during training and validation (validation), accuracy (precision), completeness (recall), Kappa-Cohen. Results: In our study, 19,379 patients were analyzed, including 15,494 men (79.95%) and 3,885 women (20.04%). At the time of the study, 6,171 men (39.8%) and 1,962 women (49.5%) were alive. Median survival was 8.3 months (SE – 0.154 months, 95% CI – 7.96-8.56) in men and 15.43 months (SE – 1.0 months, 95% CI – 13.497-17.363) in women. At diagnosis, 1,037 patients (5.35%) had stage I disease, and 4,145 (21.38%) had stage II. Most patients (61.4%) had advanced stage NSCLC: 9,189 people (47.4%) were diagnosed with stage III, and 4,655 (24%) – with stage IV. The reliability of differences in median survival (χ2=3991.6, p=0.00) indicated the prognostic significance of the tumor process stage and its influence on the patient’s survival. Also, the revealed significant difference in the median survival of patients with various morphological forms of lung cancer suggests the prognostic significance of the morphological factor (the difference between those indicators was statistically significant, χ2=623.4 p=0.000). Conclusion: Machine learning models can predict the risk of fatal outcomes for patients after surgical treatment and registration in the EROB database. The creation of patient-oriented systems to support medical decision-making makes it possible to choose the optimal strategies for adjuvant therapy, dispensary observation, and frequency of diagnostic studies.

30 September 2022 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
VMV. Makarov
V. Makarov
DKD. Kaidarova
D. Kaidarova
SYS. Yessentayeva
S. Yessentayeva
JKJ. Kalmatayeva
J. Kalmatayeva
Madina MansurovaMadina Mansurova
Madina Mansurova
INI. Novikov
I. Novikov
Relevance: The 5-year overall survival rate(s) in NSCLC p-stage IA is 73%, and the recurrence rate in radically treated patients is almost 10%. The study aimed to evaluate the prognostic significance of several clinical and morphological factors and apply machine learning algorithms to predict the results of overall survival of patients with lung cancer. Methods: The forms 030-6/y C34 – lung cancer (n=19,379) from the EROB database for 2014-2018 were analyzed, and the impact of risk factors on overall survival was assessed using the Kaplan-Meier method. Accordingly, the training data set for constructing forecasting models included 19,379 observations and 15 factors. The machine learning algorithms such as Random Forest Classifier, Gradient Boosting Classifier, Logistic Regression Model, Decision Tree Classifier, and K Nearest Neighbors (KNN) Classifier were implemented in the Python programming lan- guage. The results were evaluated by constructing an error matrix, calculating classification metrics: the proportion of correctly classified objects (accuracy) during training and validation (validation), accuracy (precision), completeness (recall), Kappa-Cohen. Results: In our study, 19,379 patients were analyzed, including 15,494 men (79.95%) and 3,885 women (20.04%). At the time of the study, 6,171 men (39.8%) and 1,962 women (49.5%) were alive. Median survival was 8.3 months (SE – 0.154 months, 95% CI – 7.96-8.56) in men and 15.43 months (SE – 1.0 months, 95% CI – 13.497-17.363) in women. At diagnosis, 1,037 patients (5.35%) had stage I disease, other 4,145 (21.38%) had stage II. Most patients (61.4%) had advanced stage NSCLC: 9,189 people (47.4%) were diagnosed with stage III, and 4,655 (24%) – with stage IV. The reliability of differences in median survival (χ2=3991.6, p=0.00) indicated the prognostic significance of the tumor process stage and its influence on the patient’s survival. Also, the revealed significant difference in the median survival of patients with various morphological forms of lung cancer sug- gests the prognostic significance of the morphological factor (the difference between those indicators was statistically significant, χ2=623.4 p=0.000). Conclusion: Machine learning models can predict the risk of fatal outcomes for patients after surgical treatment and registration in the EROB database. The creation of patient-oriented systems to support medical decision-making makes it possible to choose the optimal strategies for adju- vant therapy, dispensary observation, and frequency of diagnostic studies